Dr. Jordi Ordóñez Llanos, of the Cardiovascular Biochemistry Research Group of the IIB Sant Pau, and a clinician at the Biochemistry Service of the Hospital, has been part of the group of experts that published the document “Role of BNP vs. NT- ProBNP Testing in the Age of New Drug Therapies: Sacrolitrile-Valsartan “at Clinical Chemistry. In the publication, in the format “Questions and Answers”, a group of experts debates controversial topics of their specialty. In this case, the role of natriuretic peptides in the control of treatment with Sacubitril / Valsartan in patients with heart failure is to be clarified. Clinical Chemistry is the No. 1 journal of the Clínic Laboratory specialty.
